Rapid and Visual Detection of Type 2 Porcine Reproductive and Respiratory Syndrome Virus by Real-Time Fluorescence-Based Reverse Transcription Recombinase-Aided Amplification

Viruses. 2022 Nov 15;14(11):2526. doi: 10.3390/v14112526.

Abstract

Porcine reproductive and respiratory syndrome (PRRS) is one of the most important diseases that has brought significant economic losses to the swine industry worldwide. Rapid and accurate PRRS virus (PRRSV) detection is one of the key factors for PRRS prevention and control. This study developed a real-time fluorescence-based reverse transcription recombinase-aided amplification (RF-RT-RAA) method for type 2 PRRSV (PRRSV-2) detection. The RF-RT-RAA assay could be performed at 42 °C for 20 min with the optimal primers and a probe. RF-RT-RAA results could be monitored using real-time fluorescence read-out or visually observed with the naked eye using a portable blue light transilluminator. The method had a strong specificity; no cross-reaction was identified with the detected common swine viruses. Moreover, the technique yielded high sensitivity with the lowest detection limit of 101 copies/μL and exhibited good repeatability and reproductively with the coefficients of variation (CV) less than 10%. Eighty-seven clinical samples were tested using RF-RT-RAA and a commercial PRRSV-2 RT-qPCR detection kit. The coincidence rate was 100% between RF-RT-RAA (real-time fluorescence read-out) and RT-qPCR, and 97.7% between RF-RT-RAA (visually observed) and RT-qPCR. The RF-RT-RAA assay provides a new method for rapid and visual detection of PRRSV-2.

Keywords: porcine reproductive and respiratory syndrome virus; rapid detection; real-time fluorescence-based reverse transcription recombinase-aided amplification.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hydrolases
  • Porcine Reproductive and Respiratory Syndrome* / diagnosis
  • Porcine respiratory and reproductive syndrome virus* / genetics
  • Recombinases
  • Reverse Transcription
  • Swine

Substances

  • Recombinases
  • Hydrolases

Grants and funding

This research was funded by the National Natural Science Foundation of China (Grant No. 31902303), National Natural Science Foundation of China (Grant No. 32272995), Jiangsu Provincial Research Foundation for Basic Research of China (Grant No. BK20201063), Open Fund Project of Jiangsu Key Laboratory for Bioresources of Saline Soils (JKLBS2019010), and Opening Project of Jiangsu Province Engineering Research Center of Tumor Targeted Nano Diagnostic and Therapeutic Materials (JETNM202207).